Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care
BACKGROUND: Results of cardiovascular outcome trials enabled a shift from “treat-to-target” to “treat-to-benefit” paradigm in the management of type 2 diabetes (T2D). However, studies validating such approach are limited. Here, we examined whether treatment according to international recommendations...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738028/ https://www.ncbi.nlm.nih.gov/pubmed/36494815 http://dx.doi.org/10.1186/s12933-022-01712-4 |